早期乳腺癌患者部分乳腺照射与全乳照射的随机III期试验:丹麦乳腺癌协作组部分乳腺照射试验
丹麦乳腺癌协作组开展非劣效性随机III期试验,将低危早期乳腺癌保乳术后患者随机分配至全乳照射(WBI)或外照射部分乳腺照射(PBI),均给予40 Gy/15次。共865例可评估患者(WBI 434例,PBI 431例),主要终点为3年2-3级乳腺硬结。3年硬结率WBI为9.7%,PBI为5.1%(P=.014),PBI在乳腺硬结方面非劣效于WBI。大乳房是放射性硬结的危险因素。
要点
- 低危早期乳腺癌保乳术后,外照射PBI在乳腺硬结方面非劣效于WBI。
- 3年2-3级乳腺硬结率WBI为9.7%,PBI为5.1%(P=.014)。
- 大乳房患者3年硬结发生率WBI为13%、PBI为6%,小乳房患者WBI为6%、PBI为5%。
核心结论
- 对于低危乳腺癌患者,外照射PBI在乳腺硬结方面非劣效于WBI。
- 大乳房是放射性硬结的危险因素。
- 局部区域复发少见且与PBI无关。
研究设计与样本
- 丹麦乳腺癌协作组发起的非劣效性随机III期试验(ClinicalTrials.gov标识号NCT00892814)。
- 保乳手术后的相对低危乳腺癌患者随机分配至WBI组与PBI组,均接受40 Gy/15次。
- 主要终点为3年2-3级乳腺硬结。
- 共865例可评估患者(WBI 434例,PBI 431例),2009年至2016年间入组。
- 中位随访时间:并发症5.0年,局部区域复发7.6年。
主要发现
- 3年硬结率WBI为9.7%,PBI为5.1%(P=.014)。
- 大乳房患者3年硬结发生率WBI为13%、PBI为6%,小乳房患者WBI为6%、PBI为5%。
- PBI未增加色素沉着、毛细血管扩张、水肿或疼痛的风险,患者满意度高。
- 来曲唑和吸烟未增加放射性并发症风险。
- 16例患者出现局部区域复发(WBI 6例,PBI 10例;P=.28),20例对侧乳腺癌,8例远处失败(WBI 5例,PBI 3例)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: On the basis of low risk of local recurrence in elderly patients with breast cancer after conservative surgery followed by whole breast irradiation (WBI), the Danish Breast Cancer Group initiated the noninferiority external-beam partial breast irradiation (PBI) trial (ClinicalTrials.gov identifier: NCT00892814). We hypothesized that PBI was noninferior to WBI regarding breast induration. METHODS: Patients operated with breast conservation for relatively low-risk breast cancer were randomly assigned to WBI versus PBI, and all had 40 Gy/15 fractions. The primary end point was 3-year grade 2-3 breast induration. RESULTS: In total, 865 evaluable patients (434 WBI and 431 PBI) were enrolled between 2009 and 2016. Median follow-up was 5.0 years (morbidity) and 7.6 years (locoregional recurrence). The 3-year rate of induration was 9.7% for WBI and 5.1% for PBI (P = .014). Large breast size was significantly associated with induration with a 3-year incidence of 13% (WBI) and 6% (PBI) for large-breasted patients versus 6% (WBI) and 5% (PBI) for small-breasted patients. PBI showed no increased risk of dyspigmentation, telangiectasia, edema, or pain, and patient satisfaction was high. Letrozole and smoking did not increase the risk of radiation-associated morbidity. Sixteen patients had a locoregional recurrence (six WBI and 10 PBI; P = .28), 20 patients had a contralateral breast cancer, and eight patients had distant failure (five WBI and three PBI). A nonbreast second cancer was detected in 73 patients (8.4%), and there was no difference between groups. CONCLUSION: External-beam PBI for patients with low-risk breast cancer was noninferior to WBI in terms of breast induration. Large breast size was a risk factor for radiation-associated induration. Few recurrences were detected and unrelated to PBI.
引用
- Offersen BV, Alsner J, Nielsen HM, et al. Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial. J Clin Oncol. 2022. PMID: 35930754. doi:10.1200/JCO.22.00451
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。